Incidence and Onset of Cytomegalovirus Infection in Kidney Transplant Recipients: 3 Months Compared to 6 Months of Prophylaxis

被引：0
|
作者：
West-Thielke, P. [1 ]
Schmiedeskamp, M. [1 ]
Aggarwal, N. [1 ]
Thielke, J. [1 ]
Oberholzer, J. [1 ]
Benedetti, E. [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60680 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1547
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [11] Comparison of Cytomegalovirus Infection Risk Following 3 or 6 Months of Valganciclovir Prophylaxis Among Donor Seropositive/Recipient Seronegative Heart Transplant Recipients
    Leclerc, V.
    Chateauvert, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S638 - S639
  • [12] High incidence of clinically significant cytomegalovirus infection in CMV D plus /R plus lung transplant recipients receiving 3 months of antiviral prophylaxis
    Kabbani, Dima
    Hirji, Alim
    Hernandez, Cristina
    Malhi, Harjot
    Mabilangan, Curtis
    Chandrarathne, Sanjaya
    Halloran, Kieran
    Weinkau, Justin
    Kapasi, Ali
    Lien, Dale
    Preiksaitis, Jutta
    Cervera, Carlos
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (04)
  • [13] Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis
    Helantera, I.
    Kyllonen, L.
    Lautenschlager, I.
    Salmela, K.
    Koskinen, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (09) : 2026 - 2032
  • [14] IS THE VALACYCLOVIR PROPHYLAXIS EFFECTIVE FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS?
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 418 - 418
  • [15] IS THE VALACYCLOVIR PROPHYLAXIS EFFECTIVE FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS?
    Park, Woo Yeong
    Yeo, Sang Mok
    Park, Hayeon
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2017, 30 : 490 - 490
  • [16] PROPHYLAXIS WITH GANCICLOVIR OF CYTOMEGALOVIRUS-INFECTION IN KIDNEY-TRANSPLANT RECIPIENTS
    RONDEAU, E
    BOURGEON, B
    PERALDI, MN
    LANG, P
    BUISSON, C
    SCHULTE, KM
    WEILL, B
    SRAER, JD
    PRESSE MEDICALE, 1992, 21 (41): : 1979 - 1980
  • [17] Valganciclovir prophylaxis for 6 months prevents CMV-induced disease in 96% of kidney transplant recipients
    Cantarovich, Diego
    Giral, Magali
    Dantal, Jacques
    Blacho, Gilles
    Soulillou, Jean-Paul
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 90 - 91
  • [18] Primary CMV Infections Are Common in Kidney Transplant Recipients after 6 Months Valganciclovir Prophylaxis.
    Helantera, Ilkka
    Kyllonen, Lauri
    Lautenschlager, Irmeli
    Salmela, Kaija
    Koskinen, Petri
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 206 - 207
  • [19] High incidence of cytomegalovirus disease in D+/R- heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis
    Gupta, Sachin
    Mitchell, Joshua D.
    Markham, David W.
    Mammen, Pradeep P. A.
    Patel, Parag C.
    Kaiser, Patricia
    Ring, W. Steves
    DiMaio, J. Michael
    Drazner, Mark H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (05): : 536 - 539
  • [20] Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus
    Tedesco-Silva, H.
    Felipe, C.
    Ferreira, A.
    Cristelli, M.
    Sandes-Freitas, T.
    Oliveira, N.
    Aguiar, W.
    Bassos, G.
    Franco, M.
    Gerbase-Lima, M.
    Campos, E.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345